Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15991256rdf:typepubmed:Citationlld:pubmed
pubmed-article:15991256lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:15991256lifeskim:mentionsumls-concept:C0034493lld:lifeskim
pubmed-article:15991256lifeskim:mentionsumls-concept:C1280551lld:lifeskim
pubmed-article:15991256lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:15991256lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:15991256lifeskim:mentionsumls-concept:C0031327lld:lifeskim
pubmed-article:15991256lifeskim:mentionsumls-concept:C0681842lld:lifeskim
pubmed-article:15991256lifeskim:mentionsumls-concept:C0201734lld:lifeskim
pubmed-article:15991256lifeskim:mentionsumls-concept:C1947916lld:lifeskim
pubmed-article:15991256lifeskim:mentionsumls-concept:C0963941lld:lifeskim
pubmed-article:15991256pubmed:issue7lld:pubmed
pubmed-article:15991256pubmed:dateCreated2005-9-28lld:pubmed
pubmed-article:15991256pubmed:abstractTextTime-averaged total body clearance (Cl) and apparent volume of distribution at steady state (V(SS)) of DA-8159 after intravenous administration to mice (30 mg/kg), rats (30 mg/kg), rabbits (30 mg/kg) and dogs (3 mg/kg) were analysed as a function of species body weight (W) using the allometric equation for interspecies scaling, and were used to predict those in humans. Significant linear relationships were obtained between log Cl (l/h) and log W (kg) (r = 0.992; p = 0.0079) and log V(SS) (l) and log W (kg) (r = 0.999; p < 0.0001). The corresponding allometric equations were Cl = 4.36 W(0.492) and V(SS) = 6.41 W(0.911). These allometric equations were extrapolated to predict the Cl and V(SS) for DA-8159 in humans based on the 70 kg body weights. In addition, concentrations in the plasma-time profile predicted using the four animal data fitted to a complex Dedrick plot of animal data. Our results indicated that the DA-8159 data obtained from four laboratory animals could be utilized to generate preliminary estimates of the pharmacokinetic parameters in humans. These parameters can serve as guidelines for better planning of clinical studies.lld:pubmed
pubmed-article:15991256pubmed:languageenglld:pubmed
pubmed-article:15991256pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15991256pubmed:citationSubsetIMlld:pubmed
pubmed-article:15991256pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15991256pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15991256pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15991256pubmed:statusMEDLINElld:pubmed
pubmed-article:15991256pubmed:monthOctlld:pubmed
pubmed-article:15991256pubmed:issn0142-2782lld:pubmed
pubmed-article:15991256pubmed:authorpubmed-author:KimWon BWBlld:pubmed
pubmed-article:15991256pubmed:authorpubmed-author:ROSSVVlld:pubmed
pubmed-article:15991256pubmed:authorpubmed-author:KimYoon GYGlld:pubmed
pubmed-article:15991256pubmed:authorpubmed-author:LeeMyung GMGlld:pubmed
pubmed-article:15991256pubmed:authorpubmed-author:KwonJong WJWlld:pubmed
pubmed-article:15991256pubmed:authorpubmed-author:KimYu CYClld:pubmed
pubmed-article:15991256pubmed:authorpubmed-author:ShimHyun JHJlld:pubmed
pubmed-article:15991256pubmed:authorpubmed-author:LeeJoo HJHlld:pubmed
pubmed-article:15991256pubmed:copyrightInfoCopyright 2005 John Wiley & Sons, Ltd.lld:pubmed
pubmed-article:15991256pubmed:issnTypePrintlld:pubmed
pubmed-article:15991256pubmed:volume26lld:pubmed
pubmed-article:15991256pubmed:ownerNLMlld:pubmed
pubmed-article:15991256pubmed:authorsCompleteYlld:pubmed
pubmed-article:15991256pubmed:pagination269-77lld:pubmed
pubmed-article:15991256pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:15991256pubmed:meshHeadingpubmed-meshheading:15991256...lld:pubmed
pubmed-article:15991256pubmed:meshHeadingpubmed-meshheading:15991256...lld:pubmed
pubmed-article:15991256pubmed:meshHeadingpubmed-meshheading:15991256...lld:pubmed
pubmed-article:15991256pubmed:meshHeadingpubmed-meshheading:15991256...lld:pubmed
pubmed-article:15991256pubmed:meshHeadingpubmed-meshheading:15991256...lld:pubmed
pubmed-article:15991256pubmed:meshHeadingpubmed-meshheading:15991256...lld:pubmed
pubmed-article:15991256pubmed:meshHeadingpubmed-meshheading:15991256...lld:pubmed
pubmed-article:15991256pubmed:meshHeadingpubmed-meshheading:15991256...lld:pubmed
pubmed-article:15991256pubmed:meshHeadingpubmed-meshheading:15991256...lld:pubmed
pubmed-article:15991256pubmed:meshHeadingpubmed-meshheading:15991256...lld:pubmed
pubmed-article:15991256pubmed:meshHeadingpubmed-meshheading:15991256...lld:pubmed
pubmed-article:15991256pubmed:meshHeadingpubmed-meshheading:15991256...lld:pubmed
pubmed-article:15991256pubmed:meshHeadingpubmed-meshheading:15991256...lld:pubmed
pubmed-article:15991256pubmed:meshHeadingpubmed-meshheading:15991256...lld:pubmed
pubmed-article:15991256pubmed:meshHeadingpubmed-meshheading:15991256...lld:pubmed
pubmed-article:15991256pubmed:meshHeadingpubmed-meshheading:15991256...lld:pubmed
pubmed-article:15991256pubmed:meshHeadingpubmed-meshheading:15991256...lld:pubmed
pubmed-article:15991256pubmed:year2005lld:pubmed
pubmed-article:15991256pubmed:articleTitleInterspecies pharmacokinetic scaling of DA-8159, a new erectogenic, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.lld:pubmed
pubmed-article:15991256pubmed:affiliationCollege of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Republic of Korea.lld:pubmed
pubmed-article:15991256pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15991256pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:15991256pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15991256lld:pubmed